MHRA resumes international Inspections

Recommendation
12/13 November 2025
How to implement EU-GMP Chapter 8
Right at the start of the Covid 19 pandemic, in March 2020, the UK MHRA published a blog post on the progress of on-site inspections. These were limited to inspections related to the UK government's COVID-19 response or other potential serious public health risks. As the pandemic and developments unfolded, more on-site inspections were then carried out again in the UK. However, there was not really a return to international inspections.
Meanwhile, international travel has become easier to organise again. A pilot programme has started in April 2022 to look at a possible return to international GMP on-site inspections. In a MHRA Inspecctorate Blog entitled "Return to International GMP Inspections" now published, it is announced that the pilot project was successful and the MHRA is resuming the programme of international GMP on-site inspections, albeit with restrictions. A risk-based approach will be taken.
Validity of GMP certificates
During the pandemic, a "pragmatic approach" was taken to the validity of GMP certificates. These were first extended to the end of 2021 and then to the end of 2022. The blog now also states that GMP certificates issued by the MHRA will be extended again until the end of 2023.
Related GMP News
22.10.2025EMA Questions & Answers on Mutual Recognition Agreement (MRA) with US updated
22.10.2025FDA continues to take Root Cause Analysis and CAPA very seriously
14.10.2025Two new GDP Non-Compliance Reports from Romania
01.10.2025Alternative Inspection Methods of the FDA
24.09.2025FDA issues final Guidance on Remote Oversight Tools
24.09.2025Four Warning Letter concerning CAPA and Root Cause Analysis published


